- DNA Genetics Announces Strategic Partnership With Leading Pennsylvania Medical Cannabis Company
- LOS ANGELES, March 03, 2020 (GLOBE NEWSWIRE) — OG DNA Genetics (DNA or the Company), a globally recognized leading cannabis brand, today announced a licensing agreement (the Agreement) with PurePenn LLC (PurePenn), a leading cultivator and producer of pharmaceutical-grade cannabis capsules, concentrates, tinctures, flower and oils for the Pennsylvania market.
- For more than 15 years, genetics developed by DNA have won more than 200 awards in all categories at the most prestigious cannabis events around the world, making DNA the global standard in breeding and growing truly best-in-class strains.
- Over the last decade, the Company has built and curated a seasoned genetic library and developed proven standard operating procedures for genetic selection, breeding, and cultivation.
Read full article: globenewswire.com